• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Immunological study on the causes of cardiovascular anomalies

Research Project

Project/Area Number 02454272
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Pediatrics
Research InstitutionKagoshima University

Principal Investigator

MIYATA Koichiro  Kagoshima Univ., Medicine, Professor, 医学部, 教授 (30041411)

Co-Investigator(Kenkyū-buntansha) OKU Syozo  Kagoshima Univ.,Medicine, Research Associate, 医学部附属病院, 助手 (80224145)
IMANAKA Hiroyuki  Kagoshima Univ.,Medicine,Research Associate, 医学部附属病院, 助手 (80223329)
KAWAKAMI Kiyoshi  Kagoshima Univ., Medicine, Assistant Prof., 医学部附属病院, 講師 (50152921)
YOSHINAGA Masao  Kagoshima Univ., Medicine, Assistant Prof., 医学部附属病院, 講師 (10145469)
ONO Seigo  Kagoshima Univ.,Medicine,Associate Prof., 医学部, 助教授 (00094128)
Project Period (FY) 1990 – 1992
KeywordsCardiovascular anomalies / Rat / Anti-tissue-serum / Cell surface sugar chain / Lectin / Whole embryo culture / Leupeptin / E-64
Research Abstract

1. The production of cardiovascular malformations by combined use of protease inhibitor (leupeptin) and anti-tissue sera in the rat.
The incidence of cardiovascular anomalies was 23.4% in the combined use group. The results suggest that combined use of leupeptin and anti-heart-serum or anti-kidney-serum caused synergistic effect on the rat embryo.
2. The concentration of 14C-E64-d in each organ after intraperitoneal injection into pregnant rats.
E-64 was more concentrated in the placenta than maternal blood at 6 and 24 hours after the injection.
3. Effect of M-protein fraction(MP) of hemolytic streptococci on embryonic development in the rabbit.
After presensitization by MP, rabbits were injected with MP on day 15 of gestation. No malformation was found in the fetuses on day 29. A lightmicroscopic study revealed no myocarditis or endocarditis in the maternal hearts. These results are different from our previous data in the rat.
4. Rat whole embryo culture.
We analyzed cell surface carbohydrates changes of embryo heart using whole embryo culture. The culture started on day 9.5 post coitum, and after 3h, E-64 was added. Then the embryos were stained by 4 kinds of lectins, RCA-I, GS-II, BPA and AAA. RCA-I and GS-II binding activity was strong in the myocardium and endocardium at outflow and A-V junction of heart in the control group. But the activity was decreased in the embryos treated with E-64.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Toshio TACHIKURA: "The teratogenic effects of E-64 on rat embryogenesis." Acta Paedjatrica Japonica. 32. 495-501 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 二宮 誠他: "蛋白分解酵素阻害剤E-64投与によるラット先天奇形発生" 鹿児島大学医学雑誌. 42. 53-58 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koichiro MIYATA et al.: "Induction of cardiovascular malformations by leupeptin in the rat." Congenital Anomalies. 31. 41-45 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koichiro MIYATA et al.: "Effect of M-protein fraction of hemolytic streptococci on embryonic development in the rabbit." Medical Journal of Kagoshima University. 44. 239-243 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 鶴田 ときみ: "蛋白分解酵素阻害剤E-64投与によるラット胎仔骨形成異常" 鹿児島大学医学雑誌. 44. 229-238 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 奥 章三: "蛋白分解酵素阻害剤(ロイペプチン)と抗組織血清の組合せ投与によるラット先天奇形" 鹿児島大学医学雑誌. 44. 363-370 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koichiro MIYATA et al.: "Clark EB,Takao A,eds. Developmental Cardiology;Morphogenesis and Function" Futura Publishing Co.,Inc., 732 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 宮田 晃一郎: "新小児医学大系,小児医学の進歩'92A(実験的にみた奇形)" 中山書店, 345 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Toshio TACHIKURA: "The teratogenic effects of E-64 on rat embryogenesis" Acta. Paediatr. Jpn. 32. 495-501 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Makoto NINOMIYA, Koichiro MIYATA, Shen-Fang CHEN, Toshiro TACHIKURA, Shozo OKU, Takahisa YAMASAKI, Yuji MIZUMOTO, Makoto NAKAMURA, Hiroki NISHI: "The production of malformations by use of a protease inhibitor(E-64) in rats ( in Japanese )" Med. J. Kagoshima Univ.42. 53-58 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koichiro MIYAYTA, Akihiko KODAMA, Shen-Fang CHEN, Toshio TACHIKURA, Shozo OKU, Tagatoshi YAMASAKI, Makoto NAKAMURA: "Induction of cardiovascular malformations by leupeptin in the rat" Cong. Anom.31. 41-45 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koichiro MIYATA, Shen-Fang CHEN, Shozo OKU, Tokimi TSURUTA, Yukiisa MATSUDA, Takatoshi YAMASAKI, Makoto NAKAMURA, Hidehiko KOBAE, Yuji MIZUMOTO: "Effect of M-protein fraction of hemolytic streptococci on embryonic development in the rabbit." Med. J. Kagoshima Univ.44. 239-243 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tokimi TSURUTA: "The production of skeletal malformations by use of a protease inhibitor(E-64) in rats. ( in Japanese )" Med. J. Kagoshima Univ.44. 229-238 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shozo OKU: "The production of malformations by combined use of protease inhibitor(leupeptin) and anti-tissue sera in the rat. ( in Japanese )" Med. J. Kagoshima Univ.44. 363-370 (1992)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi